Merck may sell consumer health business to focus on new drugs

Firm, which has been present in India for over five decades, operates through five main companies

German drug maker Merck is exploring sale or strategic partnership for its consumer health business, including the unit’s India operations, as it continues its focus to develop innovative drugs.

The plan to hive off the business is the second such move by the drug maker. The company had sold its biosimilars business to another German drug maker, Fresenius Kabi, earlier this year. 

Merck operates in 66 countries and its business is spread across pharmaceuticals, laboratory solutions, chemicals and liquid crystals. In 2016, it had global sales of ^15 billion — consumer health contributed ^850 million. Merck, which has been present in India